Worth reading
68In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
10122
¥ million (year-on-year increase in net sales)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials for financial resultsFiscal year ending March 2026, full year14 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥159,664 million+6.8%
Operating profit¥9,382 million+14.5%
Ordinary income¥10,098 million+14.4%
Net income¥6,069 million+28.3%
Operating profit margin5.9 %
Full-year earnings forecast
Net Sales
1,654 Hundreds of millions of yen
Operating profit
89 Hundreds of millions of yen
By segment
Healthy Living Services
Net Sales
¥86,086 million
Operating profit
¥8,972 million
Pharmacy services
Net Sales
¥64,118 million
Operating profit
¥1,811 million
Environmental Services
Net Sales
¥15,030 million
Operating profit
¥1,202 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Above planBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
A chart shows changes in revenue and operating profit for Health and Living Services, Pharmacy Services, Environmental Services, Other, and adjustments. Individual factors listed include higher revenue, appropriate pricing, cost reductions, business consolidation, business withdrawals, revisions to drug prices and dispensing fees, and higher energy costs.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Quantitative assumptions: not disclosed. The business environment section covers soaring energy costs, revisions to drug prices and dispensing fees, demand for nursing care, tourism demand, and labor shortages.New initiatives
- Established a department responsible for M&A in the Silver Business
- Began full-scale operation of a one-stop ordering system
- Introduced an electronic statement system
- Planned introduction of AI assistants at all dispensing pharmacies from June 2026
- Expanded the medical administration operations center
- Established a department specializing in home services
- Promoting the use of cleaning robots
Key KPIsA metric the company considers important as a management benchmark.
- Number of linen-supply beds at medical institutions89,042 bedsYear on year against the same period last year-3.3%
- Number of linen-supply beds at nursing care facilities and other locations139,854 bedsYear on year against the same period last year+8.3%
- Number of sales offices for nursing care product rentals104 LocationYear on year against the same period last year+9.5%
- Number of Tanpopo Pharmacy stores at fiscal year-end161 LocationYear on year against the same period last year+1.9%
- My Number health insurance card usage rate71.6 %Year on year against the same period last year+26.4%
- Percentage of stores obtaining the medical DX system enhancement fee96.9 %
- Number of specialist pharmacists183 PeopleYear on year against the same period last year+14.4%
- Percentage of stores providing home dispensing services90.1 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
- Prescription fee per prescription¥18,745Year on year against the same period last year+10.0%
- Number of prescriptionsYear on year against the same period last yearSlight decrease year on year
Segment results
- Healthy Living ServicesNet Sales¥81,799 millionRevenue_yoy_pct6.3Operating profit¥8,546 millionOperating profit_yoy_pct19.9
- Pharmacy servicesNet Sales¥62,870 millionRevenue_yoy_pct8.3Operating profit¥2,430 millionOperating profit_yoy_pct2.2
- Environmental ServicesNet Sales¥14,837 millionRevenue_yoy_pct3.1Operating profit¥1,232 millionOperating profit_yoy_pct0.2
Medium-term management plan targets
Period CoveredFiscal years ending March 2026 to March 2028
Consolidated operating profit
Target value95 Hundreds of millions of yen
Target fiscal yearFiscal year ending March 2028
Growth Investment
Target value¥250 hundred million cumulative for 3 years
Total payout ratio
Target valueMore than 70%
Target fiscal yearCumulative for 3 years
Comparison with actual resultsFor FY3/26, revenue and operating profit both reached record highs, and initiatives in the first year progressed above plan
Financial targets
ROE
Actual results7.2 %
Medium-term target8 %
Target fiscal yearFiscal year ending March 2028
Equity ratio
Actual results73 %
Number of stores and locations
Number of stores
End of period161 Location
Stores opened during the period5
Stores closed during the period2
Number of sales locations
End of period104 Location
Capital expenditures
¥5,865 million
Annual Dividend
Annual¥80 per share
Interim¥40 per share
End of period¥40 per share
Payout ratio
40.4 %
Total payout ratio
140.4 %
Acquisition of treasury shares
ImplementationShare repurchases and cancellations conducted in November 2025
PeriodNovember 2025
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | ¥159,664 million (YoY +6.8%) |
| Operating profit | ¥9,382 million (YoY +14.5%) |
| Ordinary income | ¥10,098 million (YoY +14.4%) |
| Net income | ¥6,069 million (YoY +28.3%) |
| Operating profit margin | 5.9 % |
| Full-year earnings forecast | Net Sales 1,654 Hundreds of millions of yen / Operating profit 89 Hundreds of millions of yen / By segment Healthy Living Services Net Sales ¥86,086 million / Operating profit ¥8,972 million / Pharmacy services Net Sales ¥64,118 million / Operating profit ¥1,811 million / Environmental Services Net Sales ¥15,030 million / Operating profit ¥1,202 million |
| Self-assessment against the plan | Above plan |
| Segment results | Segment Healthy Living Services / Net Sales ¥81,799 million / Revenue_yoy_pct 6.3 / Operating profit ¥8,546 million / Operating profit_yoy_pct 19.9, Segment Pharmacy services / Net Sales ¥62,870 million / Revenue_yoy_pct 8.3 / Operating profit ¥2,430 million / Operating profit_yoy_pct 2.2, Segment Environmental Services / Net Sales ¥14,837 million / Revenue_yoy_pct 3.1 / Operating profit ¥1,232 million / Operating profit_yoy_pct 0.2 |
| Breakdown of Factors Affecting the Change | A chart shows changes in revenue and operating profit for Health and Living Services, Pharmacy Services, Environmental Services, Other, and adjustments. Individual factors listed include higher revenue, appropriate pricing, cost reductions, business consolidation, business withdrawals, revisions to drug prices and dispensing fees, and higher energy costs. |
| Key KPIs | Indicator Number of linen-supply beds at medical institutions / Value 89,042 beds / Year on year against the same period last year -3.3 beds, Indicator Number of linen-supply beds at nursing care facilities and other locations / Value 139,854 beds / Year on year against the same period last year 8.3 beds, Indicator Number of sales offices for nursing care product rentals / Value 104 Location / Year on year against the same period last year 9.5 Location, Indicator Number of Tanpopo Pharmacy stores at fiscal year-end / Value 161 Location / Year on year against the same period last year 1.9 Location, Indicator My Number health insurance card usage rate / Value 71.6 % / Year on year against the same period last year 26.4 %, Indicator Percentage of stores obtaining the medical DX system enhancement fee / Value 96.9 % / Year on year against the same period last year Not disclosed, Indicator Number of specialist pharmacists / Value 183 People / Year on year against the same period last year 14.4 People, Indicator Percentage of stores providing home dispensing services / Value 90.1 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Indicator Prescription fee per prescription / Value ¥18,745 / Year on year against the same period last year ¥10, Indicator Number of prescriptions / Value Not disclosed / Year on year against the same period last year Slight decrease year on year |
| Number of stores and locations | Number of stores End of period 161 Location / Stores opened during the period 5 / Stores closed during the period 2 / Number of sales locations End of period 104 Location |
| Assumptions Underlying the Business Outlook | Quantitative assumptions: not disclosed. The business environment section covers soaring energy costs, revisions to drug prices and dispensing fees, demand for nursing care, tourism demand, and labor shortages. |
| Medium-term management plan targets | Period Covered Fiscal years ending March 2026 to March 2028 / Consolidated operating profit Target value 95 Hundreds of millions of yen / Target fiscal year Fiscal year ending March 2028 / Growth Investment Target value ¥250 hundred million (cumulative for 3 years) / Total payout ratio Target value More than 70% / Target fiscal year Cumulative for 3 years / Comparison with actual results For FY3/26, revenue and operating profit both reached record highs, and initiatives in the first year progressed above plan |
| Financial targets | ROE Actual results 7.2 % / Medium-term target 8 % / Target fiscal year Fiscal year ending March 2028 / Equity ratio Actual results 73 % |
| Annual Dividend | Annual ¥80 per share / Interim ¥40 per share / End of period ¥40 per share |
| Payout ratio | Value 40.4 % / Total payout ratio Value 140.4 % |
| Acquisition of treasury shares | Implementation Share repurchases and cancellations conducted in November 2025 / Amount Not disclosed / Number of Shares Not disclosed / Period November 2025 |
| Capital expenditures | ¥5,865 million |
| New initiatives | Established a department responsible for M&A in the Silver Business, Began full-scale operation of a one-stop ordering system, Introduced an electronic statement system, Planned introduction of AI assistants at all dispensing pharmacies from June 2026, Expanded the medical administration operations center, Established a department specializing in home services, Promoting the use of cleaning robots |
Items this document does not state (9)
Gross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastNumber of employeesRisk amount incorporated into the outlookOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, growth in revenue from the core rental business and an increase in prescriptions for high-priced pharmaceuticals, the contribution from higher revenue in the dispensing pharmacy business, and lower costs through more efficient use of rental equipment in the Silver Business all contributed to results. For the fiscal year ending March 2027, the company expects higher energy costs at laundry plants, lower technical fee revenue due to revisions to drug prices and dispensing fees, and higher one-time costs associated with the introduction of cleaning robots.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.